Anti-PCSK9 antibody pharmacokinetics and low-density lipoprotein-cholesterol pharmacodynamics in nonhuman primates are antigen affinity-dependent and exhibit limited sensitivity to neonatal Fc receptor-binding enhancement (Q46112689)
Jump to navigation
Jump to search
scientific article published on 4 February 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anti-PCSK9 antibody pharmacokinetics and low-density lipoprotein-cholesterol pharmacodynamics in nonhuman primates are antigen affinity-dependent and exhibit limited sensitivity to neonatal Fc receptor-binding enhancement |
scientific article published on 4 February 2015 |
Statements
1 reference
Anti-PCSK9 antibody pharmacokinetics and low-density lipoprotein-cholesterol pharmacodynamics in nonhuman primates are antigen affinity-dependent and exhibit limited sensitivity to neonatal Fc receptor-binding enhancement (English)
1 reference
Kirk R Henne
1 reference
Brandon Ason
1 reference
Monique Howard
1 reference
Wei Wang
1 reference
Jeonghoon Sun
1 reference
Jared Higbee
1 reference
Jie Tang
1 reference
Katherine C Matsuda
1 reference
Ren Xu
1 reference
Lei Zhou
1 reference
Joyce C Y Chan
1 reference
Chadwick King
1 reference
Derek E Piper
1 reference
Randal R Ketchem
1 reference
Mark Leo Michaels
1 reference
Simon M Jackson
1 reference
Marc W Retter
1 reference
4 February 2015
1 reference
353
1 reference
1
1 reference
119-131
1 reference